Microparticle-Delivered Cxcl9 Prolongs Braf Inhibitor Efficacy in Melanoma.
Romano G, Paradiso F, Li P, Shukla P, Barger LN, El Naggar O, Miller JP, Liang RJ, Helms TL, Lazar AJ, Wargo JA, Taraballi F, Costello JC, Kwong LN.
Romano G, et al. Among authors: paradiso f.
Cancer Immunol Res. 2023 May 3;11(5):558-569. doi: 10.1158/2326-6066.CIR-22-0224.
Cancer Immunol Res. 2023.
PMID: 36820825
Free PMC article.